People found that the fasting glucose of rs553668A carriers was significantly higher than that of noncarriers, and they have reduced insulin secretion and higher Adra2a mRNA expression, and this increased the risk of T2D [18, 25, 26]. Here, ADRA2A is linked to type 2 diabetes mellitus.